您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(医学版)》

山东大学学报(医学版) ›› 2017, Vol. 55 ›› Issue (5): 86-90.doi: 10.6040/j.issn.1671-7554.0.2017.111

• 临床医学 • 上一篇    下一篇

血清miR-17-92簇在HPV阳性宫颈癌中的早期诊断价值

刘京康1,杨建勇2,孟丽华1,姜洁1   

  1. 1.山东大学齐鲁医院妇产科, 山东 济南 250012;2.平原县第一人民医院麻醉科, 山东 平原 253100
  • 收稿日期:2017-02-04 出版日期:2017-05-10 发布日期:2017-05-10
  • 通讯作者: 姜洁. E-mail:qljiangjie@sdu.edu.cn E-mail:qljiangjie@sdu.edu.cn
  • 基金资助:
    国家自然科学基金(81372808);山东大学基本科研业务费(2082015QLMS44)

The value of serum miR-17-92 cluster in early diagnosis of HPV-positive cervical cancer

LIU Jingkang1, YANG Jianyong2, MENG Lihua1, JIANG Jie1   

  1. 1. Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, Jinan 250012, Shandong, China;
    2. First Peoples Hospital of Pingyuan County, Pingyuan 253100, Shandong, China
  • Received:2017-02-04 Online:2017-05-10 Published:2017-05-10

摘要: 目的 检测miR-17-92簇成员分子(miR-17、miR-18a、miR-19a、miR-19b、miR-20a和miR-92a)在人乳头瘤病毒(HPV)阳性宫颈癌(CC)及上皮内瘤变(CIN)患者血清中的表达水平,并评估其对HPV阳性宫颈癌的早期诊断价值。 方法 收集HPV阳性宫颈癌患者150例(CC组)、HPV阳性CIN1~3级患者100例(CIN组)及单纯HPV阳性或子宫良性病变者150例(对照组)血清,采用实时定量PCR(RT-qPCR)法检测血清中miR-17-92簇成员分子的表达,结合液基薄层细胞学检测(TCT)结果,评价miR-17-92簇成员分子在HPV阳性宫颈癌中的早期诊断价值。 结果 与对照组相比,miR-18a和miR-92a在CC组血清中异常高表达,且其表达水平显著高于CIN组及对照组,两者在CIN3级患者中的表达水平及miR-18a在CIN1-2级患者中的表达水平均显著高于对照组(P均<0.05)。受试者工作曲线(ROC曲线)分析结果显示,血清miR-18a诊断CIN3及CC(CIN3+)的曲线下面积(AUC)为0.792(95%CI:0.749~0.862),灵敏度为87%,特异度为65%;血清miR-92a诊断CIN3+的AUC为0.799(95%CI:0.744~0.847),灵敏度为55.8%,特异度为92%;TCT诊断CIN3+的AUC为0.645(95%CI:0.582~0.704),灵敏度为51.9%,特异度为77%。血清miR-18a和miR-92对宫颈癌和CIN3+的诊断效能均显著优于TCT检测(P均<0.01)。 结论 miR-17-92簇成员分子miR-92a和miR-18a在HPV阳性宫颈癌患者血清中高表达,并可作为HPV阳性宫颈癌的早期诊断及鉴别高级别CIN的潜在标志物。

关键词: 宫颈癌, 宫颈上皮内瘤变, miR-17-92簇, 人乳头瘤病毒, 血清

Abstract: Objective To detect the expression levels of miR-17-92 cluster(miR-17, miR-18a, miR-19a, miR-19b, miR-20a and miR-92a)in the serum from patients with cervical cancer(CC)and cervical intraepithelial neoplasia(CIN), and to evaluate their clinical significance in the early diagnosis of human papillomavirus(HPV)positive cervical cancer. Methods Serum samples were collected from 150 HPV positive CC patients(cancer group), 100 HPV-positive patients with CIN1-3(CIN group)and 50 HPV-positive women without malignant disease(control group). RT-qPCR was performed to analyze the expression levels of serum miR-17-92 cluster. The diagnostic values of the differently expressed miRNAs were evaluated and compared with Thinprep cytologic test(TCT). Results The expression 山 东 大 学 学 报 (医 学 版)55卷5期 -刘京康,等.血清miR-17-92簇在HPV阳性宫颈癌中的早期诊断价值 \=-of serum miR-18a and miR-92a were significantly higher in CC group than in CIN group and control group; the expression of serum miR-18a and miR-92a were significantly higher in CIN group than in control group; the expression of miR-18a was significantly higher in CIN1-2 patients than in control group(all P<0.05). Receiver operating characteristic(ROC)curve analysis revealed that the area under the curve(AUC)of serum miR-18a, miR-92a and TCT for identifying CIN3 and CC(CIN3+)was 0.792(95%CI: 0.749-0.862; sensitivity: 87%; specificity: 65%), 0.799(95%CI: 0.744-0.847; sensitivity: 55.8%; specificity: 92%)and 0.645(95%CI: 0.582-0.704; sensitivity: 51.9%; specificity: 77%), respectively. Compared with TCT, detection of serum miR-18a and miR-92a achieved higher performance efficiency for identifying CIN3+(all P<0.01). Conclusion MiR-18a and miR-92a, the members of miR-17-92 cluster, are highly expressed in the serum of HPV-positive patients with cervical cancer, and could serve as potential biomarkers for early diagnosis of cervical neoplasia and high-grade CIN identification.

Key words: Cervical cancer, Cervical intraepithelial neoplasia, MiR-17-92 cluster, Human papillomavirus, Serum

中图分类号: 

  • R711
[1] Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017[J]. CA Cancer J Clin, 2017, 67(1): 7-30.
[2] Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2): 115-132.
[3] He L, Thomson JM, Hemann MT, et al. A microRNA polycistron as a potential human oncogene[J]. Nature, 2005, 435(7043): 828-833.
[4] 姚烜, 张灵敏, 汪洋, 等. miR-17-92基因簇反义寡核苷酸对胃癌细胞增殖与侵袭的抑制作用[J]. 现代肿瘤医学, 2011, 19(5): 852-855. YAO Xuan, ZHANG Lingmin, WANG Yang, et al. Effect of miR-17-92 cluster on proliferation and metastasis of human gastric cancer cell line SGC-7901[J]. Modern Oncology, 2011, 19(5): 852-855.
[5] Ke TW, Wei PL, Yeh KT, et al. MiR-92a promotes cell metastasis of colorectal cancer through PTEN-Mediated PI3K/AKT pathway[J]. Ann Surg Oncol, 2015, 22(8): 2649-2655.
[6] Honegger A, Schilling D, Bastian S, et al. Dependence of intracellular and exosomal microRNAs on viral E6/E7 oncogene expression in HPV-positive tumor cells[J]. PLoS Pathog, 2015, 11(3): 1004712.
[7] Naucler P, Ryd W, Törnberg S, et al. Human papillomavirus and papanicolaou tests to screen for cervical cancer[J]. N Engl J Med, 2007, 357(16): 1589-1597.
[8] Kitchener HC, Almonte M, Thomson C, et al. HPV testing in combina -tion with liquid-based cytology in primary cervical screening(ARTISTIC): a randomised controlled trial[J]. Lancet Oncol, 2009, 10(7): 672-682.
[9] Mayrand MH, Duarte-Franco E, Rodrigues I, et al. Human papillomavi-rus DNA versus Papanicolaou screening tests for cervical cancer[J]. N Engl J Med, 2007, 357(16): 1579-1588.
[10] Ronco G, Giorgi-Rossi P, Carozzi F, et al. Efficacy of human papillo -mavirus testing for the detection of invasive cervical cancers and cervi-cal intraepithelial neoplasia: a randomised controlled trial[J]. Lancet Oncol, 2010, 11(3): 249-257.
[11] Whitlock EP, Vesco KK, Eder M, et al. Liquid-based cytology and human papillomavirus testing to screen for cervical cancer: a system -atic review for the U.S. Preventive Services Task Force[J]. Ann Intern Med, 2011, 155(10): 687-697.
[12] 李红, 李铤, 刘常浩, 等.循环血清miR-17-92簇: 一种新的胃癌诊断标志物[J]. 现代肿瘤医学, 2014, 22(3): 581-585. LI Hong, LI Ting, LIU Changhao, et al. Circulating miR-17-92 cluster in serum: novel potential biomarkers for gastric cancer[J]. Modern Oncology, 2014, 22(3): 581-585.
[13] Puerta-Gil P, Garcia-Baquero R, Jia AY, et al. miR-143, miR-222, and miR-452 are useful as tumor stratification and noninvasive diagnostic biomarkers for bladder cancer[J]. Am J Pathol, 2012,180(5): 1808-1815.
[14] Cui L, Zhang X, Ye G, et al. Gastric juice MicroRNAs as potential biomarkers for the screening of gastric cancer[J]. Cancer, 2013, 119(9): 1618-1626.
[15] 徐臣光, 陈静, 许践刚, 等. 血清miRNA作为结直肠癌患者诊断标志物的价值研究[J].肿瘤学杂志, 2015, 21(5): 405-410. XU Chenguang, CHEN Jing, XU Jiangang, et al. Study on the role of serum microRNA as diagnostic biomarker for colorectal cancer patients[J]. Journal of Chinese Oncology, 2015, 21(5): 405-410.
[16] Wang X, Wang HK, Li Y, et al. MicroRNAs are biomarkers of oncogenic human papillomavirus infections[J]. Proc Natl Acad Sci U S A, 2014, 111(11): 4262-4267.
[17] Su Z, Yang H, Zhao M, et al. MicroRNA-92a Promotes cell proliferation in cervical cancer via inhibiting p21 expression and promoting cell cycle progression[J]. Oncol Res, 2017, 25(1): 137-145.
[18] Zhou C, Shen L, Mao L, et al. MiR-92a is upregulated in cervical cancer and promotes cell proliferation and invasion by targeting FBXW7[J]. Biochem Biophys Res Commun, 2015, 458(1): 63-69.
[19] Chiantore MV, Mangino G, Iuliano M, et al. Human papillomavirus E6 and E7 oncoproteins affect the expression of cancer-related microRNAs: additional evidence in HPV-induced tumorigenesis[J]. J Cancer Res Clin Oncol, 2016, 142(8): 1751-1763.
[20] Kong Q, Tang Z, Xiang F, et al. Diagnostic Value of serum hsa-mir-92a in patients with cervical cancer[J]. Clinical Laboratory, 2017, 63(2): 335-340.
[1] 李波波 李道堂 刘曙光 王兴武. 食管癌患者血清中DKK-1的表达[J]. 山东大学学报(医学版), 2209, 47(6): 58-61.
[2] 张辉 时庆 侯怀水 李栋. 人脐带间充质干细胞的无动物血清培养及向肝细胞诱导分化[J]. 山东大学学报(医学版), 2209, 47(6): 88-.
[3] 李宁 张征 张宏群 高希宝. 济南居民膳食硒摄入量与血清硒参考值调查[J]. 山东大学学报(医学版), 2209, 47(6): 121-122.
[4] 张媛 李英敏 冯月秋 常彩云 潘华伟 王束玫. 血清脂联素水平与肥胖、胰岛素抵抗的关系探讨[J]. 山东大学学报(医学版), 2209, 47(6): 124-.
[5] 王磊,常霄,王梓萌,李娇娇,崔书君,杨飞,朱月香. 瘤内及瘤周DCE-MRI影像组学对宫颈癌患者无进展生存期的预测价值[J]. 山东大学学报 (医学版), 2025, 63(6): 45-54.
[6] 杜雪,李春霞,刘云霞,张涛. 基于MFPC-Cox的结直肠癌患者预后动态预测模型[J]. 山东大学学报 (医学版), 2025, 63(5): 101-110.
[7] 石军,牛子捷,王军,马丽晶,奚春花,肖洋. 幼年型复发性呼吸道乳头状瘤病肺部播散的临床特点及麻醉要点[J]. 山东大学学报 (医学版), 2024, 62(12): 82-89.
[8] 任慧欣,郑茂金,韩文灿,王超群,周云,裴冬生. 过氧化氢通过调控自噬增强宫颈癌的放疗敏感性[J]. 山东大学学报 (医学版), 2023, 61(6): 22-28.
[9] 刘萌,侯丛哲,麻焕玉,张震,赵新蕊,张萍,朱琳. β-雌二醇对宫颈癌Hela细胞增殖的影响[J]. 山东大学学报 (医学版), 2023, 61(2): 9-15.
[10] 孙继业,王紫欧,孙晓伟,李洪涛. 中药熏蒸联合体外冲击波对72例髋关节撞击综合征临床疗效、血清炎症因子水平的影响[J]. 山东大学学报 (医学版), 2022, 60(4): 76-81.
[11] 修德健,高正文,宋婷婷,崔楠,崔静,孙健平. 生物信息学方法分析与宫颈癌有关联的基因[J]. 山东大学学报 (医学版), 2022, 60(10): 99-109.
[12] 陈泉材,韩赛,刘露,孙雨,尤学武,张俊华,张友忠. CDC7、MCM4在105例宫颈病变组织中的表达及意义[J]. 山东大学学报 (医学版), 2022, 60(1): 34-39.
[13] 蔡春芳,易丹妮,郭芝亮,何耀娟. P16蛋白与TCT、HR-HPV的相关性及对不同子宫颈病变诊断的效能[J]. 山东大学学报 (医学版), 2022, 60(1): 40-47.
[14] 王璐,赵新蕊,朱琳. 25例早期宫颈癌无瘤化免举宫腹腔镜子宫切除术临床效果[J]. 山东大学学报 (医学版), 2021, 59(6): 76-80.
[15] 梁婷婷,杨勇霞,侯丛哲,黄太胜,王华丽,朱琳. PAX1基因甲基化与宫颈高级别上皮内病变及高危型HPV分型的关联性[J]. 山东大学学报 (医学版), 2021, 59(11): 48-52.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!